Skip to main content
OpenTrials

Clinical trial condition

Lymphoma, Extranodal NK-T-Cell

Explore clinical trials studying Lymphoma, Extranodal NK-T-Cell. Study availability and eligibility vary by location and protocol.

160 public trials 17 recruiting studies
Refine in advanced search Browse all conditions

Lymphoma, Extranodal NK-T-Cell trial results

Active, not recruiting

Vorinostat and Azacitidine in Treating Patients With Locally Recurrent or Metastatic Nasopharyngeal Cancer or Nasal Natural Killer T-Cell Lymphoma

NCT00336063

Conditions
Adult Nasal Type Extranodal NK/T-cell Lymphoma, Lymphoma, Lymphoma, Extranodal NK-T-Cell, +8 more
Locations
  • Johns Hopkins University/Sidney Kimmel Cancer Center Baltimore, Maryland, United States
  • Chinese University of Hong Kong-Prince of Wales Hospital Shatin, Hong Kong
  • National Cancer Center Hospital Tokyo, Japan
  • National University Hospital Singapore Singapore
View Trial Details
Active, not recruiting

Cholecalciferol in Improving Survival in Patients With Newly Diagnosed Cancer With Vitamin D Insufficiency

NCT01787409

Conditions
Aggressive Non-Hodgkin Lymphoma, Anaplastic Large Cell Lymphoma, Angioimmunoblastic T-cell Lymphoma, +40 more
Locations
  • Mayo Clinic in Arizona Scottsdale, Arizona, United States
  • Emory University/Winship Cancer Institute Atlanta, Georgia, United States
  • University of Iowa/Holden Comprehensive Cancer Center Iowa City, Iowa, United States
  • Mayo Clinic Rochester, Minnesota, United States
View Trial Details
Active, not recruiting

A Study to Assess the Safety, Tolerability, Efficacy, and Drug Levels of BMS-986369 (Golcadomide) in Participants With Relapsed or Refractory T-cell Lymphomas in Japan (GOLSEEK-3)

NCT06035497

Conditions
Disease Attributes, Hematologic Diseases, Hemic and Lymphatic Diseases, +26 more
Locations
  • Local Institution - 0031 Anjo-shi, Aichi-ken, Japan
  • Local Institution - 0011 Nagoya, Aichi-ken, Japan
  • Local Institution - 0024 Toyohashi, Aichi-ken, Japan
  • Local Institution - 0017 Kamogawa, Chiba, Japan
View all 40 locations
View Trial Details
Active, not recruiting

A Study of IMC-001 in Subjects With Relapsed or Refractory Extranodal NK/T Cell Lymphoma, Nasal Type

NCT04414163

Conditions
Extranodal NK/T-cell Lymphoma, Extranodal NK/T-cell Lymphoma, Nasal Type, Lymphoma, +5 more
Locations
  • Chonnam National University Hwasun Hospital Gwangju, South Korea
  • Asan Medical Center Seoul, South Korea
  • Samsung Medical Center Seoul, South Korea
  • Seoul National University Hospital Seoul, South Korea
View Trial Details

Related conditions